If your dose requires more than 1.5mL, the pool of liquid under your tongue becomes too large to maintain without swallowing
Recent epidemiological data indicate an overall incidence of MASLD ranging from 46.1 to 46.9 new cases per 1,000 person-years, with a prevalence estimated at 30.05% to 32.4%
Coverage gaps also emerge when switching doses or adjusting treatment frequency, as many BCBS plans limit quantity dispensed per fill or restrict refill timing
Without that cushion, your face may look thinner but it can also appear gaunt, with sagging cheeks, jowls, or loose skin along the jawline
Athauda D, Maclagan K, Budnik N, Zampedri L, Hibbert S, Aviles-Olmos I, et al
In preclinical studies, GIPR/GLP-1R co-agonism produces less nauseating effects compared to GLP-1R agonism alone as measured by kaolin intake in mice and rats and emetic events in musk shrews (69)